184 related articles for article (PubMed ID: 9566815)
1. mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity.
Bilkei-Gorzó A; Gyertyán I; Lévay G
Psychopharmacology (Berl); 1998 Apr; 136(3):291-8. PubMed ID: 9566815
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety.
Gommans J; Hijzen TH; Pattij T; van der Gugten J; Olivier B
Pharmacol Biochem Behav; 1999 Oct; 64(2):385-7. PubMed ID: 10515318
[TBL] [Abstract][Full Text] [Related]
3. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
4. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.
Shimada T; Matsumoto K; Osanai M; Matsuda H; Terasawa K; Watanabe H
Gen Pharmacol; 1995 Jan; 26(1):205-10. PubMed ID: 7713361
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
Shepherd JK; Grewal SS; Fletcher A; Bill DJ; Dourish CT
Psychopharmacology (Berl); 1994 Sep; 116(1):56-64. PubMed ID: 7862931
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
Sánchez C
Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
[TBL] [Abstract][Full Text] [Related]
7. A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety.
Wallis CJ; Lal H
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):547-65. PubMed ID: 9612850
[TBL] [Abstract][Full Text] [Related]
8. [The effect of isotheoline on mouse behavior under test conditions for detecting its anxiolytic activity].
Zheliazkova-Savova M
Eksp Klin Farmakol; 1998; 61(3):19-21. PubMed ID: 9690069
[TBL] [Abstract][Full Text] [Related]
9. Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.
Gibson EL; Barnfield AM; Curzon G
Neuropharmacology; 1994; 33(3-4):457-65. PubMed ID: 7984284
[TBL] [Abstract][Full Text] [Related]
10. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
Kennett GA; Whitton P; Shah K; Curzon G
Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
[TBL] [Abstract][Full Text] [Related]
12. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
Strauss CV; Vicente MA; Zangrossi H
Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
14. The use of sudden darkness in mice: a behavioural and pharmacological approach.
Bert B; Felicio LF; Fink H; Nasello AG
Psychopharmacology (Berl); 2005 Jun; 179(4):846-53. PubMed ID: 15619112
[TBL] [Abstract][Full Text] [Related]
15. A fully automated light/dark apparatus useful for comparing anxiolytic agents.
Young R; Johnson DN
Pharmacol Biochem Behav; 1991 Dec; 40(4):739-43. PubMed ID: 1687762
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats.
Meert TF; Melis W; Aerts N; Clincke G
Behav Pharmacol; 1997 Aug; 8(4):353-63. PubMed ID: 9832994
[TBL] [Abstract][Full Text] [Related]
17. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
Merlo Pich E; Samanin R
Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
[TBL] [Abstract][Full Text] [Related]
18. The elevated T-maze as an experimental model of anxiety.
Graeff FG; Netto CF; Zangrossi H
Neurosci Biobehav Rev; 1998; 23(2):237-46. PubMed ID: 9884116
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
Silverstone PH; Cowen PJ
Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
[TBL] [Abstract][Full Text] [Related]
20. Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.
Sant'Ana AB; Vilela-Costa HH; Vicente MA; Hernandes PM; de Andrade TGCS; Zangrossi H
Neuropharmacology; 2019 Apr; 148():311-319. PubMed ID: 30685402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
